Drugs / Pure oxygen
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05467215 | Jul 2022 → Dec 2026 expected | spinal cord injury | University of Alberta | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pure oxygen | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05467215 ↗ |
| Route | Other | “delivered through a face mask” NCT05467215 ↗ |